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In Latin American and Caribbean (LAC) countries, the number of cases of dog-mediated  
human rabies is at its lowest since the onset of the Regional Program for Rabies 
Elimination in 1983, a commitment from LAC countries to eliminate dog-mediated rabies 
coordinated by the Pan American Health Organization. Despite minor setbacks, the 
decline in the number of human cases has been constant since 1983. While many LAC 
countries have significantly reduced rabies to a level where it is no longer significant 
public health concern, elimination has proven elusive and pockets of the disease remain 
across the region. In the 33-year period since 1983, the region has set and committed 
to four dates for elimination (1990, 2000, 2012, and 2015). In this paper, we ponder 
on the multiple causes behind the elusive goal of rabies elimination, such as blanket 
regional goals oblivious to the large heterogeneity in national rabies capacities. Looking 
ahead to the elimination of dog-mediated rabies in the region, now established for 2022, 
we also review the many challenges and questions that the region faces in the last 
mile of the epidemic. Given the advanced position of the Americas in the race toward 
elimination, our considerations could provide valuable knowledge to other regions 
pursuing elimination goals.
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iNtrODUctiON
In 1983, when dog-mediated rabies in the American region was the cause of over 200 human deaths 
and 12,000 dog cases per year, representatives from the countries, gathered at the first Regional 
Meeting of Rabies Program Directors (REDIPRA) (1) coordinated by the Pan American Health 
Organization (PAHO/WHO), had the vision of a future free of dog-mediated rabies. Armed with 
nerve tissue vaccine for dogs, they launched a region-wide plan leading to mass dog vaccination 
campaigns across the region and set up the first elimination goal for the Americas, by 1990. Three 
other elimination goals followed in 2000, 2012, and 2015. Although the goal was not achieved by 
2015, the coordinated regional efforts toward elimination led to the control of dog-mediated rabies 
in most of the Americas. At the time of writing, eight dog-mediated human rabies cases have been 
reported across the region in 2016, all in Haiti.
In the following, we ponder on the possible reasons that may have contributed to the four missed 
elimination goals to date, and specifically target the final years of the regional control program. We 
then speculate on the main challenges that lay ahead. Our considerations, necessarily from a regional 
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perspective, are based on the experience of the region in the race 
toward elimination and could provide valuable knowledge to 
other regions pursuing similar goals.
cHALLeNGes PAst AND FUtUre
On Program Management
At the announcement during the last REDIPRA meeting in 
2015 (1) that the fourth elimination goal was not going to be 
achieved, PAHO and the countries did not establish another 
deadline, but agreed on a pathway toward the definition of the 
next goal. Two possible future goals were discussed: (i) elimina-
tion of canine rabies or (ii) elimination of dog-mediated human 
rabies. Countries chose the latter, as they did on the previous four 
occasions. Regardless of the scope of the goal, countries agreed to 
the recommendation that the new date for elimination had to be 
based on the systematic evaluation of countries’ rabies capabili-
ties. This approach to goal setting differs from the previous four 
that led to arbitrary elimination dates that failed to recognize 
the heterogeneous development of rabies capabilities among 
countries.
Proactively coordinated, the aggregated evaluation of coun-
tries’ rabies capacities, and their improvement plans toward 
disease elimination should inform the earliest date at which the 
region would be able to eliminate the disease. Moreover, the 
aggregation of gaps from all countries would inform the regional 
demand for specific capacities, e.g., rabies vaccine, some of which 
could be more efficiently provided by a regional mechanism (e.g., 
PAHO’s Revolving Fund) (1).
The development of a systematic evaluation framework of 
the countries capacities is thus critical. Such a framework would 
require the definition of regional standards and indicators as well 
as clear requirements regarding the nature and quality of the 
evidence needed to support control and elimination claims. A 
PAHO review of indicators used by the countries to monitor the 
performance of their rabies programs identified large heterogene-
ity, in the number of indicators per country, from just a few to 
more than 100, and in the nature of them, from process indicators 
to outcome indicators (2).
The importance of the regular REDIPRA meetings, which 
constitute the strategic governance platform of rabies programs 
in the region, cannot be underestimated. Group dynamics 
prevalent at these meetings exercise great influence on strategic 
issues that cannot be replicated remotely. Specifically, we stress 
the importance of peer-pressure among countries. In addition, 
regional coordination requires formal structures to facilitate 
regular networking in the interval between REDIPRA meetings, 
e.g., via working groups around specific products such as inter-
laboratory proficiency exercises (1).
On coordination, we must mention stakeholder engagement, 
even if briefly, and specifically one of the most salient actors in 
recent years, i.e., animal rights groups. The engagement of officials 
with these groups was not always productive and, at times, led to 
departures from the real focus on rabies control. But a change 
at both camps appears evident in recent years. Both sides have 
learned to moderate their message, and now understand that 
negotiation and not confrontation leads to better outcomes for 
all. Official programs start to recognize that these groups need to 
be brought to the discussion table at the planning stages, as they 
can deliver niche-specific approaches to local problems.
On evidence
The impact of interventions can only be monitored with reliable 
data. Since 1998, PAHO has been collecting data via question-
naires to the countries on their programs’ performance prior to 
the regular REDIPRA meetings. It was only at the most recent 
REDIPRA in 2015 that a thorough analysis of the data could be 
presented (1).
Earlier reports stated that a number of Latin American and 
Caribbean (LAC) countries were conducting excellent rabies sur-
veillance (3). These results seem to concur with those reported by 
zoonosis managers to a survey in early 2015 who replied that they 
were satisfied with the sensitivity of their rabies surveillance (4). 
However, to the best of our knowledge, and with the exception of 
Haiti (5), there is no systematic evaluation of rabies surveillance 
in the region, and we are not aware of recent patient chart reviews 
of acute encephalitis or sensitivity estimation of dog surveillance. 
Specifically on the latter, the region, by large, follows the recom-
mendation of sampling a proportion of the dog population (3). 
This, at best, has facilitated discussions on the importance of tar-
geting dogs for early warning and, at worst, has drained resources 
without informing the epidemiology of the disease. Recent work 
supported by PAHO questions this approach to surveillance 
and suggests more efficient alternatives (6). These studies also 
show the importance of variant identification, especially at the 
end game, and are a reminder that some countries in the region 
still lack this capacity in-house, or even nimble mechanisms to 
acquire it elsewhere for prompt response to cases.
The investigations that followed the recent occurrence of 
multiple dog cases in Brazil (7), spanning to more than one 
local authority, highlighted fundamental structural problems, 
not rabies-specific, for the generation of sound evidence, i.e., 
the absence of a common standard for data gathering across 
administrative units. This is likely to resonate in other countries, 
and it highlights the need for a standard epidemiological report. 
To that effect, the region will benefit from the ongoing efforts by 
Brazil toward the harmonization of processes across its network 
of zoonosis’ surveillance units.
The regional rabies database, SIRVERA (8), despite all its 
shortcomings, has played a critical role in the success of the 
regional program. A perhaps overlooked contribution is that 
SIRVERA is the most tangible product of the program across 
its many years and participating countries. Together with other 
“brands” of the program (e.g., REDIPRA), SIRVERA has bundled 
the countries around the regional goal. That is, those countries 
that contribute data to it. Three countries where rabies is still 
endemic have consistently failed to report to SIRVERA. Such 
failure to report not only impacts on the ability of the program 
to monitor regional progress, but it has important consequences 
on neighboring areas pursuing control and elimination as they 
struggle to assess the risk of incursion from such countries. Like 
the other capacities, SIRVERA needs to change to adapt to the 
end game too and become the exhaustive repository of rabies 
programs performance indicators in the region. In other words, it 
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must not just chase cases but also track and identify substandard 
capacity planning and deployment that constitute the best early 
warning of rabies risk.
On resources
A prolonged epidemic tail, consecutive goal failures and farther 
in time goals, contribute to investors’ fatigue (in the case of the 
Americas, these are mainly government budget holders, with 
external donors playing a much limited role, except for Haiti). 
It is a well-described fact that short-term goals lead to greater 
willingness to invest (9). The opposite can lead to reduced donor 
engagement. Efforts to attract resources must contemplate break-
ing down long-term regional goals, to reduce the long payback 
period, into country and area-specific objectives with short- and 
medium-term deliverables linked to enhanced capacity deploy-
ment to attract more investors/donors seeking quick returns. 
In other words, investment opportunities need to be indexed to 
processes and capacities that are fully measurable, tractable, and 
prone to direct influence. Moreover, short-term successes, e.g., 
the declaration of an increasing number of rabies-free countries 
and areas along the way, would reduce the perception of uncer-
tainty around the overall investment for regional elimination, 
farther ahead.
Efforts to attract investment must also recognize that at the 
end game, there is little room for inefficiencies. As a result, 
optimization of regional and national resource allocation 
schemes, e.g., by country or geographical area vs. by capacity, 
merits study to prevent underperforming assets from receiving 
undeserved support (10, 11). This tendency may stem from 
failure to accept underperforming capacities relative to others, 
or a lack of appreciation of the full scope of opportunity costs. 
This might well be the case of devoting scarce resources to dog 
sterilization, an intervention that delivers a much lesser punch 
at a much greater cost than dog vaccination. Inefficient invest-
ment will only prolong the tail end of the epidemic, directly 
resulting in further cases and unnecessary deaths and, as a 
result, increasing the risk of goal fatigue. Other inefficiencies, 
either at the national or regional level, could occur as a result of 
maintaining vaccine production facilities for reduced domestic 
demand, unsubstantiated dog surveillance strategies that lead to 
no useful evidence for decision making, or the current prophy-
laxis schemes (PEP), promoting intramuscular administration, 
prevalent across the region.
On vaccination
Notwithstanding occasional problems, all countries in the 
region, except for those that have been free from rabies for 
years, plan the purchase of vaccine (for humans and dogs) in 
their annual budgets. This, in comparison with other regions, is a 
feast. Not all, though, manage to acquire the vaccine at all (most 
notably Haiti), or in the quantities and timelines needed. The 
insufficient deployment of vaccine, whether in control or elimi-
nation stages, is the ultimate reason as to why rabies persists in 
some of those countries. Insufficient dog vaccine deployment, 
due to deficient population coverage, untested vaccine quality, 
mismanagement of batches, and non-compliance with protocol, 
translates into failure to consistently achieve herd immunity in 
a number of scattered locations that remain endemic, even if 
undetected. Occasional donations and exchanges of vaccines 
between countries, whether brokered by PAHO or not, have 
been the norm in the past to supply vaccine to areas in acute 
need (3, 12). This solidarity may be threatened as more areas 
reach elimination in the region, and hence reduce the size of 
their rabies programs and vaccine stockpiles. In such a scenario, 
where one single exposure may delay the region’s goal, a regional 
mechanism to guarantee rapid deployment of rabies vaccines 
merits consideration.
Following on our remarks about the limited appetite for inef-
ficiencies at the last mile, dog vaccine application must seek ways 
to reduce repeated vaccination of easy-to-reach animals. Beyond 
the financial implications, these animals contribute to vaccine 
coverage indicators, despite bringing no additional immunity, 
and may lead to a false sense of achievement about herd protec-
tion in the targeted dog population.
Rabies programs across the region have benefited from the 
incorporation of human rabies vaccine in the countries’ regular 
acquisition of biologicals through PAHO’s purchasing mecha-
nisms. In 2014, following recommendations from REDIPRA 
(13), PAHO also included the dog vaccine in its portfolio of 
biologicals on offer through the PAHO revolving fund. Via large 
purchases, PAHO guarantees the provision of quality vaccine 
at competitive prices, and, most importantly, promotes regular 
budgeting practices in the countries. Improvements are possi-
ble, for example, by incorporating human rabies vaccine in the 
well-established logistical systems of the Expanded Programme 
on Immunization in country. This is a work in progress after a 
communication by PAHO to that effect was sent to the countries 
last year.
Despite seeing the lowest human case count in over 30 years, 
the demand for human rabies vaccine is on the rise. If human 
vaccine sold by PAHO’s purchasing mechanisms is a good proxy 
for the overall use across the region, bearing in mind that not 
all the LAC countries buy through PAHO, we have noted an 
average increase of over 55,000 doses of human vaccine every 
year for the period 2005–2015. In 2015 alone, circa of 900,000 
doses were acquired via PAHO’s revolving fund. Although alter-
native dog surveillance systems, such as those based on tracking 
exposures after reported bites, could lead to more efficient PEP 
application (6), rabies programs must prepare for long-lasting 
demand of PEP even in the absence of canine rabies cases for 
quite some time.
On Awareness
In contrast to the evident scars left by smallpox, or other dis-
eases with obvious sequelae, rabies does not leave living bearers 
to remind us of its occurrence. Together with the declining 
incidence, awareness of the disease will wane. This phenomenon 
will only get worse, and it would be important to regularly moni-
tor the levels of awareness among the population in risk areas. 
Activities to that effect, e.g., knowledge-attitudes and practices 
surveys, may deliver collateral benefits by capturing heightened 
risk perception among the population that may provide suffi-
cient reason, in the absence of adequate surveillance, for policy 
intervention.
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A decrease in awareness may also lead to reduced uptake of 
preventive measures as seen in other diseases, e.g., measles vac-
cine. For rabies, the impact might be twofold: leading to reduced 
dog vaccination, and PEP uptake and prescription by health 
staff after exposure. The latter was the target of the recent rabies 
alerts issued by PAHO after a number of cases in the region (14). 
However, no similar alerts were issued after evidence of insuf-
ficient dog rabies vaccines coverage in risk areas. This, again, 
highlights the reactive nature of the program chasing cases and 
not capacities (or their absence).
FiNAL reMArKs
It has been said that the regional rabies elimination program is a 
victim of its own success, as reduced disease incidence leads to 
relaxation of controls, and new evidence needs at the end game 
challenge attitudes and practices that worked well during the con-
trol phase, but may not do so well during the last mile. Given the 
regional success, some resistance to accept innovations tested in 
other settings, as is the case of intradermal human rabies vaccine 
or the use of capture–recapture methods to estimate dog vaccine 
coverage, is expected. Transferring successful approaches from 
well-controlled projects in local settings elsewhere is not without 
difficulty as managers tend to dismiss them as generated from 
different contexts of little applicability to their own. This may be 
true, given well-known limitations in external validity of even 
the most robust investigations (15). However, the merit of these 
well-controlled studies elsewhere is undeniable, and the region is 
now benefiting from such findings in the formulation of canine 
surveillance guidance and area level classification.
Basic problem structuring theory identifies two types of com-
plexities in every problem and decision setting to its resolution: 
technical or analytical complexities, and organizational com-
plexities (16). For rabies in the Americas, where effective tools 
are available for its control and elimination, disease persistence is 
due to organizational failure at the planning, implementation, or 
evaluation of the rabies program. Specifically, failure to (i) gather 
and properly present the evidence about disease risk and vulner-
abilities to budget holders, (ii) systematically generate synergies 
with other programs and stakeholders to ensure efficient capacity 
deployment, and (iii) conduct thorough risk assessment on the 
sustainability of the rabies program. We recognize the impact 
of externalities on any disease program, but for dog rabies and 
the Americas, the authors believe that contextual factors play a 
critical role in one country alone: Haiti.
Improvements are underway. The regional program has 
now developed a framework for evaluation of rabies capacities, 
commissioned research to robustly guide dog surveillance 
requirements (5) and classify areas based on a composite 
measure of risk (17), and recently released a new SIRVERA 
platform capable of managing all the evidence needs in the 
elimination phase (8). These tools come with a price. They 
need increasing amounts of quality and timely data to provide 
the required precision, around results of interventions such 
as dog vaccine coverage, to support robust and opportune 
decision-making.
Reaching out to countries to promote reporting as per the new 
data standards and to support the shift in focus toward monitor-
ing capacities and vulnerabilities, and not just cases, will require 
increased resources by the regional program. The additional 
resource will have to be distributed across endemic, at risk and 
free areas. Although the most obvious targets are the endemic 
and at risk classes, the region must also capitalize on those 
areas that achieve freedom. To that effect, the regional program 
needs to formalize the processes around rabies elimination and 
maintenance of such status and demand thorough risk analysis by 
countries that contemplate interventions beyond their borders in 
collaboration with areas still posing a risk.
Good as a planned approach may be, elimination requires 
more than cold preparation. Failure to reach the 2015 elimina-
tion goal should have generated a state of crisis to justify major 
transformational changes in the regional program. Without such 
changes, in the form of a state of urgency to propel the commit-
ment to prompt elimination, the risk of apathy is real. Without 
consideration of the intangible benefits stemming from elimina-
tion, mostly of a political nature, the cold calculations around 
the diminishing returns of additional disease control measures at 
this stage may lead to the perpetuation of the current situation. 
This would betray the vision of those colleagues over 30 years ago. 
Without the pressure of an imminent goal, there are no regional 
consequences as a result of a new case, beyond the tragic death of 
a human being by a shameful disease.
The recently approved “Plan of Action for the elimination of 
neglected infectious diseases and post-elimination actions 2016–
2022” (18), should deliver the new impetus, and the resources, 
to reach rabies elimination by 2022. Of mention is the inclusion 
in this plan, for the first time, of a reference to the elimination of 
canine rabies transmission.
AUtHOr cONtriBUtiONs
VV conceived and wrote the work. All the authors have criti-
cally reviewed and revised the manuscript and approved it for 
publication.
reFereNces
1. Pan American Health Organization (PAHO/WHO). Regional Meeting 
of National Rabies Programme Managers in the Americas (REDIPRA). 
(2015). Available from: http://www.paho.org/panaftosa/index.php?option= 
com_content&view=article&id=211&Itemid=397
2. Del Rio Vilas VJ, Burgeño A, Montibeller G, Clavijo A, Vigilato MA, Cosivi 
O. Prioritization of capacities for the elimination of dog-mediated human 
rabies in the Americas: building the framework. Pathog Glob Health (2013) 
107(7):340–5. doi:10.1179/2047773213Y.0000000122 
3. Vigilato MAN, Clavijo A, Knobl T, Tamayo Silva HM, Cosivi O, Schneider 
MC, et al. Progress towards eliminating canine rabies: policies and perspec-
tives from Latin America and the Caribbean. Philos Trans R Soc Lond B Biol 
Sci (2013) 368(1623):20120143. doi:10.1098/rstb.2012.0143 
4. Maxwell MJ, Carvalho MJ, Del Rio Vilas VJ. Building the road towards 
a regional zoonoses strategy: a survey of zoonoses programs in the 
Americas. Online J Public Health Inform (2015) 8(1). doi:10.5210/ojphi.v8i1. 
6436 
5. Wallace RM, Reses H, Franka R, Fenelon N, Orciari L, Etheart M, et  al. 
Establishment of a canine rabies burden in Haiti through the implementation 
5Del Rio Vilas et al. Tribulations of the Last Mile
Frontiers in Veterinary Science | www.frontiersin.org January 2017 | Volume 4 | Article 4
of a novel surveillance program. PLoS Negl Trop Dis (2015) 9(11):e0004245. 
doi:10.1371/journal.pntd.0004354
6. Hampson K, Brunker K, Mancero T, Caldas E, Carvalho M, Castro A, et al. 
Surveillance to establish elimination of transmission and freedom from 
dog-mediated rabies. Proceeding of the 2016 RITA (Rabies in the Americas) 
Meeting. Belem, Pará, Brazil (2016).
7. Arruda da Silva W, Campos Ametlla V, Soares Juliano R. Raiva canina no 
municipio de Corumba-MS, 2015: relato de caso. Acta Veterinaria Brasilica 
(2015) 9(4):386–90. 
8. Rocha F, Molina Flores B, Buzanovsky L, Santos AG, Carvalho M, Vigilato 
MAN, et  al. SIRVERA: Atualizaçao Para Melhoria Da Qualidade De 
Informaçao Sobre Raiva Nas Americas. Proceeding of the 2016 RITA (Rabies 
in the Americas) Meeting. Belem, Pará, Brazil (2016).
9. Conlon D, Garland H. The role of project completion information in resource 
allocation decisions. Acad Manage J (1993) 36:402–13. doi:10.2307/256529 
10. Scharfstein D, Stein J. The dark side of internal capital markets: divisional 
rent-seeking and inefficient investment. J Finance (2000) 55(6):2537–64. 
doi:10.1111/0022-1082.00299 
11. Bromiley P. A prospect theory model of resource allocation. Decis Anal (2009) 
6:124–38. doi:10.1287/deca.1090.0142 
12. Millien MF, Pierre-Louis JB, Wallace R, Caldas E, Rwangabgoba JM, 
Poncelet JL, et al. Control of dog mediated human rabies in Haiti: no time 
to spare. PLoS Negl Trop Dis (2015) 9(6):e0003806. doi:10.1371/journal.pntd. 
0003806 
13. Pan American Health Organization (PAHO/WHO). Regional Meeting 
of National Rabies Programme Managers in the Americas (REDIPRA). 
(2013). Available from: http://www.paho.org/panaftosa/index.php?option= 
com_content&view=article&id=211&Itemid=397
14. Pan American Health Organization (PAHO/WHO). Rabies Epidemiological 
Alert. (2014). Available from: http://www.paho.org/hq/index.php?option= 
com_docman&task=doc_view&gid=25409&Itemid=270
15. Wandersman A, Alia K, Cook BS, Hsu LL, Ramaswamy R. Evidence-based 
interventions are necessary but not sufficient for achieving outcomes 
in each setting in a complex world: empowerment evaluation, getting 
to outcomes, and demonstrating accountability. Am J Eval (2016):1–18. 
doi:10.1177/1098214016660613
16. McNamee P, Celona J. Decision Analysis for the Professional. Stanford, CA: 
SmartOrg Inc (2008). 225 p.
17. Rysava K, Mancero T, Caldas E, Carvalho M, Gutierrez V, Haydon D, et al. 
Surveillance tools to guide rabies elimination programmes. Online J Public 
Health Inform (in press). 
18. Pan American Health Organization (PAHO/WHO). Plan of Action for 
the Elimination of Neglected Infectious Diseases and Post-Elimination 
Actions 2016-2022. (2016). Available from: http://www.paho.org/hq/index.
php?option=com_content&view=article&id=12547%3Aamericas-aim-to- 
eliminate-8-neglected-infectious-diseases-control-5-other-next-6-years& 
catid=8882%3A55-dc-news&Itemid=42099&lang=en
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
The handling editor declared a past co-authorship with one of the authors MV and 
states that the process nevertheless met the standards of a fair and objective review.
Copyright © 2017 Del Rio Vilas, Freire de Carvalho, Vigilato, Rocha, Vokaty, Pompei, 
Molina Flores, Fenelon and Cosivi. This is an open-access article distributed under the 
terms of the Creative Commons Attribution License (CC BY). The use, distribution or 
reproduction in other forums is permitted, provided the original author(s) or licensor 
are credited and that the original publication in this journal is cited, in accordance 
with accepted academic practice. No use, distribution or reproduction is permitted 
which does not comply with these terms.
